ALX Oncology Insider Trades
NASDAQ: ALXOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $5.00M
- Sales
- 7 · $42.59K
- Shares bought / sold
- 3.18M / 21.91K
- Net activity
- Net buying $5.0 million
ALX Oncology insider activity
Over the last 12 months, ALX Oncology insiders reported 9 transactions on SEC Form 4: 1 open-market purchase and 7 sales. Insiders bought $5.0 million and sold $42,588 worth of stock, for net insider buying of $5.0 million. The largest seller was Lettmann Jason, with $31,019 in reported sales.
The most recent filing shows Lettmann Jason (CHIEF EXECUTIVE OFFICER) selling 2,230 shares at $1.93 on Aug 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ALXO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ALXO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 17, 2026 | Wong ShellySVP, FINANCE AND CAO | Sale | 573 | $1.11K | Form 4 |
| Aug 17, 2026 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Sale | 2,230 | $4.30K | Form 4 |
| Jul 1, 2026 | Wong ShellySVP, FINANCE AND CAO | Sale | 1,404 | $2.86K | Form 4 |
| Mar 19, 2026 | Pinto ShellySVP, FINANCE AND CAO | Sale | 903 | $1.96K | Form 4 |
| Mar 19, 2026 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Sale | 12,311 | $26.71K | Form 4 |
| Feb 18, 2026 | Pinto ShellySVP, FINANCE AND CAO | Sale | 565 | $1.28K | Form 4 |
| Feb 17, 2026 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Tax withholding | 2,201 | $5.00K | Form 4 |
| Feb 2, 2026 | GOODMAN COREY SDirector | Buy | 3,184,713 | $5.00M | Form 4 |
| Jan 6, 2026 | Pinto ShellySVP, FINANCE AND CAO | Sale | 3,925 | $4.36K | Form 4 |
| Sep 17, 2025 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Buy | 71,163 | $76.89K | Form 4 |
| Sep 16, 2025 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Buy | 21,070 | $22.46K | Form 4 |
| Aug 18, 2025 | Shantharam HarishChief Financial Officer | Buy | 75,000 | $58.40K | Form 4 |
| Aug 15, 2025 | Pinto ShellySVP, FINANCE AND CAO | Sale | 611 | $391.28 | Form 4 |
| Aug 15, 2025 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Sale | 2,382 | $1.53K | Form 4 |
| Jul 7, 2025 | Pinto ShellySVP, FINANCE AND CAO | Sale | 2,011 | $905.15 | Form 4 |
| Jun 30, 2025 | Pinto ShellySVP, FINANCE AND CAO | Sale | 1,532 | $658.76 | Form 4 |
| Mar 14, 2025 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Award | 42,000 | — | Form 4 |
| Mar 14, 2025 | Pinto ShellySVP, FINANCE AND CAO | Award | 3,000 | — | Form 4 |
| Feb 19, 2025 | Pons JaumePRESIDENT & CSO | Sale | 1,326 | $1.53K | Form 4 |
| Feb 19, 2025 | Pinto ShellySVP, FINANCE AND CAO | Sale | 550 | $632.61 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4